Table 1 Comparison between all studied patients’ data before and after treatment
All patients | Before treatment | After treatment (at SVR12) | p-value | |
|---|---|---|---|---|
No. = 100 | No. = 100 | |||
Hb (gm/dl) | Mean ± SD Range | 13.90 ± 1.11 11.3–15.7 | 13.05 ± 1.11 10.5–15 | 0.000 |
WBC (× 10^3/μl) | Mean ± SD Range | 6.89 ± 1.67 3.9–11.7 | 6.42 ± 1.56 4–11 | 0.000 |
PLT (× 10^3/μl) | Mean ± SD Range | 144.14 ± 31.28 108–260 | 138.19 ± 31.35 95–256 | 0.000 |
AST (U/l) | Mean ± SD | 58.85 ± 31.85 | 27.57 ± 9.90 | 0.000 |
Range | 20–124 | 14–52 | ||
ALT (U/l) | Mean ± SD | 53.54 ± 28.39 | 23.96 ± 8.92 | 0.000 |
Range | 15–115 | 12–48 | ||
S. alb. (g/dl) | Mean ± SD | 3.88 ± 0.40 | 4.28 ± 0.40 | 0.000 |
Range | 3.2–4.9 | 3.6–5.3 | ||
INR | Mean ± SD | 1.02 ± 0.14 | 1.00 ± 0.06 | 0.120 |
Range | 0.1–1.2 | 0.9–1.1 | ||
T. bil. (mg/dl) | Mean ± SD | 0.87 ± 0.29 | 0.63 ± 0.18 | 0.000 |
Range | 0.5–1.6 | 0.4–1.2 | ||
D. bil. (mg/dl) | Median (IQR) | 0.2 (0.1–0.4) | 0.07 (0.03–0.2) | 0.000 |
Range | 0.03–0.9 | 0.01–0.6 | ||
BMI | Mean ± SD | 28.31 ± 1.53 | 28.07 ± 1.52 | 0.000 |
Range | 24–31 | 23.5–30.5 | ||
FBS (mg/dl) | Mean ± SD Range | 120.26 ± 5.09 108–125 | 110.70 ± 10.68 13–120 | 0.000 |